Overexpression of FADD enhances 5-fluorouracil-induced apoptosis in colorectal adenocarcinoma cells

Medical Oncology

Volumn 27, Issue 2, 2010, Pages 397-405

  Yin, Anning ^a   Jiang, Yingan ^a   Zhang, Xianfeng ^a   Luo, Hesheng ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

5 Fluorouracil; Apoptosis; Colorectal adenocarcinoma; Fas associated death domain protein (FADD)

Indexed keywords

CASPASE 3; CASPASE 8; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLUOROURACIL;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL VIABILITY; CHEMOSENSITIVITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SW480 CELL; SW480 NEO CELL; TUMOR XENOGRAFT; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77956897987     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9224-x     Document Type: Article

References (33)

1. Etzioni DA, El-Khoueiry AB, Beart RW Jr. Rates and predictors of chemotherapy use for stage III colon cancer: a systematic review. Cancer. 2008;113(12):3279-89. doi:10.1002/cncr.23958.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96. doi:10.3322/CA. 2007.0010.
3. Lim YJ, Rhee JC, Bae YM, Chun WJ. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. World J Gastroenterol. 2007;13(13):1947-52.
4. Pinedo HM, Peters GF. 5-Fluorouracil: biochemistry and pharmacology. J Clin Oncol. 1988;6(10):1653-64.
5. Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labianca R, et al. A pool-ed analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001;345(15): 1091-7. doi:10.1056/NEJMoa010957.
6. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995;81(4):505-12. doi:10.1016/0092-8674(95)90071-3.
7. Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer- Avni Y, et al. Self-association of the "death domains" of the 55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J Biol Chem. 1995; 270(1):387-91. doi:10.1074/jbc.270.1.387.
8. Kim PK, Dutra AS, Chandrasekharappa SC, Puck JM. Genomic structure and map-ing of human FADD, an intracellular mediator of lymphocyte apoptosis. J Immunol. 1996;157(12):5461-6.
9. Thorburn A. Death receptor-induced cell killing. Cell Signal. 2004;16(2):139-44. doi:10.1016/j.cellsig.2003.08.007. (Pubitemid 37431163)
10. Kondo S, Ishizaka Y, Okada T, Kondo Y, Hitomi M, et al. FADD gene therapy for malignant gliomas in vitro and in vivo. Hum Gene Ther. 1998;9(11):1599-608. doi:10.1089/hum.1998.9.11- 1599.
11. Kobayashi T, Okamoto K, Kobata T, Hasunuma T, Kato T, et al. Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes. Gene Ther. 2000;7(6):527-33. doi:10.1038/sj. gt.3301127.
12. Yoshikawa R, Kusunoki M, Yanagi H, Noda M, Furuyama JI, et al. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res. 2001; 61(3):1029-37.
13. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322(6):352-8.
14. Benson AB 3rd. New approaches to assessing and treating earlystage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease. Clin Cancer Res. 2007;13(22):6913-20. doi:10.1158/1078-0432.CCR-07- 1188. (Pubitemid 350206839)
15. Andre N, Schmiegel W. Chemoradiotherapy for colorectal cancer. Gut. 2005;54(8):1194-202. doi:10.1136/gut.2004.062745. (Pubitemid 41025919)
16. Andre' T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J,et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatmentfor colon cancer. N Engl J Med. 2004;350(23):2343-51. doi:10.1056/NEJMoa032709. (Pubitemid 38702845)
17. Lecomte T, Ferraz JM, Zinzindohoue' F, Loriot MA, Tregouet DA, et al. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracilbased chemotherapy. Clin Cancer Res. 2004;10(17):5880-8. doi: 10.1158/1078-0432.CCR-04-0169. (Pubitemid 39180969)
18. Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer. 2005;5(11):876-85. doi:10.1038/ nrc1736.
19. Holler N, Zaru R, Micheau O, Thome M, Attinger A, et al. Fastriggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000;1(6):489-95. doi:10.1038/82732.
20. Imai T, Adachi S, Nishijo K, Ohgushi M, Okada M, et al. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells. Oncogene. 2003;22(58):9231-42. doi:10.1038/sj.onc.120 184.
21. Shimada K, Nakamura M, Ishida E, Kishi M, Yonehara S, et al. Phosphorylation of Fas-associated death domain contributes to enhancement of etoposide-induced apoptosis in prostate cancer cells. Jpn J Cancer Res. 2002;93(10):1164-74.
22. Keiji S, Syuichi M, Mitsutoshi N, Eiwa I, Munehiro K, et al. Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis. Carcinogenesis. 2004;25(7):1089-97. doi:10.1093/carcin/bgh130. (Pubitemid 38968037)
23. Micheau O, Solary E, Hammann A, Dimanche-Boitrel MT. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol. Chem. 1999;274(12):7987-92. doi:10.1074/jbc.274.12. 7987. (Pubitemid 29144270)
24. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 1996;85(6):803-15. doi:10.1016/S0092-8674(00)81265-9.
25. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, et al. FLICE, a novel FADD-homologous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death- inducing signaling complex. Cell. 1996;85(6):817-27. doi: 10.1016/S0092-8674(00)81266-0. (Pubitemid 26193033)
26. Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, et al. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med. 1998;187(4):587-600. doi:10.1084/jem.187.4.587. (Pubitemid 28093361)
27. Astrin SM. Are there molecular targets for therapy of colon cancer? Oncology (Williston Park). 1991;5(10):127-32.
28. Sabaawy HE, Farley T, Ahmed T, Feldman E, Abraham NG. Synergetic effects of retrovirus IFN-alpha gene transfer and 5-FU on apoptosis of colon cancer cells. Acta Haematol. 1999;101(2): 82-8. doi:10.1159/000040929.
29. Durai R, Yang SY, Seifalian AM, Winslet MC. Principles and applications of gene therapy in colon cancer. J Gastrointestin Liver Dis. 2008;17(1):59-67.
30. Dong F, Wang L, Davis JJ, Hu W, Zhang L, et al. Eliminating established tumor in nu/nu nude mice by a tumor necrosis factoralpha- related apoptosis-inducing ligand-armed oncolytic adenovirus. Clin Cancer Res. 2006;12(17):5224-30. doi:10.1158/1078- 0432.CCR-06-0244.
31. Lipinski KS, Djeha AH, Ismail T, Mountain A, Young LS, et al. High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue. Mol Ther. 2001;4(4):365-71. doi:10.1006/mthe.2001.0468. (Pubitemid 33040522)
32. Choi EA, Lei H, Maron DJ, Mick R, Barsoum J, et al. Combined 5-fluorouracil/systemic interferon-beta gene therapy results in long-term survival in mice with established colorectal liver metastases. Clin Cancer Res. 2004;10(4):1535-44. doi:10.1158/ 1078-0432.CCR-0040-03.
33. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94(3):491-501. doi:10.1016/S0092-8674(00)81590-1.